articleTop 1% cited

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

New England Journal of Medicine · 1998 · Vol. 338(13) · pp. 853–860

Frank J. Palella✉Kathleen M. Delaney(Research Network (United States))Anne C. MoormanMark O. Loveless(Oregon Health & Science University)Jack Fuhrer(State University of New York)Glen A. SattenDiane Aschman(Research Network (United States))Scott D. Holmberg

View via DOI Publisher page

Abstract

The recent declines in morbidity and mortality due to AIDS are attributable to the use of more intensive antiretroviral therapies.

HIV Research and Treatment HIV/AIDS drug development and treatment HIV/AIDS Research and InterventionsMedicineMortality ratePneumoniaInternal medicineIncidence (geometry)Esophageal candidiasisOpportunistic infectionPediatricsImmunologyViral disease

MeSH terms

Acquired Immunodeficiency SyndromeAdultCytomegalovirus InfectionsDrug Therapy, CombinationDrug UtilizationFemaleHumansInsurance, HealthMaleMiddle AgedPneumonia, PneumocystisUnited StatesMycobacterium avium-intracellulare InfectionIncidenceAIDS-Related Opportunistic Infections

Citations

9,489

FWCI

111.47

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy